Tesla sales careened lower in Germany in January, as sales of the electric vehicle company headed by Elon Musk tumble across Europe. The TV spot marks the artificial-intelligence company's biggest ...

Then’ is sponsored by Brown Harris Stevens Realtors Joanne Santulli, Karen Ceraso, Bettina Hegel and Schuyler Morris. Mr.

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Eli Lilly shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue.

Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its Zepbound ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Booming sales of its blockbuster incretin-based weight loss and diabetes drugs Mounjaro and Zepbound powered Eli Lilly (LLY) to a 45% jump in ...

A Medical Mystery” and “The Body Transplant” among other novels, radiology professor Heike Daldrup-Link uses storytelling to highlight challenges in healthcare and society.

This is the shocking moment a group of furious female workers beat up a British tourist at a Thai bar with their high heels ...

Nicola Twilley on the quest for artificial blood. Plus: how the Oscar race got as messy as “Conclave”; the U.S.-Soviet search ...

But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model ...